AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 58 filers reported holding AURA BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,726,993 | -28.1% | 526,978 | -1.0% | 4.02% | -29.7% |
| Q2 2023 | $6,574,313 | +30.3% | 532,333 | -2.1% | 5.72% | -6.4% |
| Q1 2023 | $5,045,304 | -13.3% | 543,675 | -1.9% | 6.11% | -8.7% |
| Q4 2022 | $5,820,003 | +43.0% | 554,286 | +146.8% | 6.69% | +34.1% |
| Q3 2022 | $4,069,000 | +12.8% | 224,554 | -11.8% | 4.99% | +28.6% |
| Q2 2022 | $3,608,000 | – | 254,622 | – | 3.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $66,878,000 | 18.12% |
| Decheng Capital Management III (Cayman), LLC | 210,000 | $4,620,000 | 1.42% |
| Matrix Capital Management Company, LP | 4,112,870 | $90,483,000 | 1.09% |
| Rock Springs Capital Management LP | 1,008,114 | $22,179,000 | 0.56% |
| Nantahala Capital Management | 301,990 | $6,644,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,297,019 | $28,534,000 | 0.05% |
| Citadel Advisors | 2,316,653 | $48,263,000 | 0.01% |
| Allianz Asset Management GmbH | 55,145 | $1,213,000 | 0.00% |
| BARCLAYS PLC | 59,697 | $1,314,000 | 0.00% |
| FMR LLC | 494,109 | $10,870,000 | 0.00% |